<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308217">
  <stage>Registered</stage>
  <submitdate>14/07/2009</submitdate>
  <approvaldate>21/06/2011</approvaldate>
  <actrnumber>ACTRN12611000631909</actrnumber>
  <trial_identification>
    <studytitle>Vitamin D Deficiency in Human Immunodeficiency Virus</studytitle>
    <scientifictitle>The effect of Cholecalciferol and dietary advice on Vitamin D levels in participants with Human Immunodeficiency Virus Infection</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>'Nil'</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Vitamin D Deficiency</healthcondition>
    <healthcondition>Human Immundeficiency Infection</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Infection</conditioncode1>
      <conditioncode2>Acquired immune deficiency syndrome (AIDS / HIV)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Supplementation with 5000 IU Cholecalciferol orally, daily for 12 months, in addition to a single 30 minute interview with dietitian at baseline with provision of dietary advice regarding sources of vitamin D in diet plus advice regarding safe levels of sunlight exposure</interventions>
    <comparator>No comparator</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Proportion of Human Immunodeifiency Virus (HIV) patients who achieve normal Vitamin D levels (&gt;50 nmol/l) measured by blood analysis</outcome>
      <timepoint>12 months following supplementation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Effect of vitamin D supplementation on bone markers (Calcium, phosphate, Alkaline Phosphatase, Parathryroid Hormone) by blood assays</outcome>
      <timepoint>12 months following supplementation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Effect of vitamin D supplementation on immunological markers (CD4 lymphocyte cell counts) by blood assays</outcome>
      <timepoint>12 months following supplementation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Documented HIV infection
Age greater than 18 years
Vitamin D deficiency (&lt;50 nmol/l)</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Pregnancy
On vitamin D supplementation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Once an HIV patient with vitamin D deficiency is identified, they are referred for consideration of volunteering to participate in the study. All patents will be prescribed the intervention. No concealment procedures.</concealment>
    <sequence>Not applicable</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>2/07/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>The Alfred Hospital Research Trust</primarysponsorname>
    <primarysponsoraddress>Commercial Rd
Melbourne
Victoria, 3004</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>The Alfred Hospital Research Trust</fundingname>
      <fundingaddress>Commercial Rd
Melbourne
Victoria, 3004</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Merck, Sharp &amp; Dohme</fundingname>
      <fundingaddress>54-68 Ferndell St 
South Granville, NSW, 2142</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of the study is to measure the prevalence of vitamin D deficiency in the HIV population at the Alfred Hospital, and then to evaluate the effectiveness of vitamin D supplementation in this population.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Alfred Hospital Research and Ethics Committee</ethicname>
      <ethicaddress>Commercial Rd
Melbourne
Victoria, 3004</ethicaddress>
      <ethicapprovaldate>2/07/2009</ethicapprovaldate>
      <hrec>AH 118/09</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Miss Julia Price</name>
      <address>Nutrition Department
The Alfred Hospital
Commercial Rd
Melbourne
Victoria, 3004</address>
      <phone>+61 3 9076 3063</phone>
      <fax />
      <email>J.Price@alfred.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Miss Julia Price</name>
      <address>Nutrition Department
Alfred Hospital
Commercial Rd
Melbourne
Victoria, 3004</address>
      <phone>+61 3 9076 3063</phone>
      <fax />
      <email>J.Price@alfred.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Jennifer Hoy</name>
      <address>Infectious Diseases Unit
The Alfred Hospital
Commercial Rd
Melbourne
Victoria, 3004</address>
      <phone>+61 3 9076 6900</phone>
      <fax />
      <email>Jennifer.Hoy@med.monash.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>